Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma
Open Access
- 7 August 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-17
Abstract
Alterations in the diversity and abundance of oncogenic gene transcripts are key factors driving tumor initiation and progression. DCLK1, an emerging cancer stem cell marker, is activated during tumorigenesis, triggering cancer stemness and metastasis. It produces long or short isoforms through selective usage of alternative promoters (α- or β-promoter). However, the mechanism mediating DCLK1 activation and choice of AP model in cancer remains unclear. Herein, we reveal that DCLK1 is significantly activated, with a concomitant alternative-promoter model switch (β-to-α) towards the long variants (isoform 1 and 2) in clear cell renal cell carcinoma (ccRCC). During tumorigenesis, the α-promoter is initiated with an improved probability from 31.6% to 61.1%, whereas the initiation probability of the β-promoter declined from 68.4% to 38.9%. Mechanistically, this alteration is mediated by a hypoxia-HIF2α-PLOD2 axis, which further activates β-catenin to selectively bind and activate the α-promoter. Our findings also showed that the hyperactivated PLOD2-DCLK1-L axis in ccRCC is correlated with a higher EMT signature and predicts an unfavorable prognosis in ccRCC patients, while disrupting this signaling by pharmacological targeting of DCLK1-L significantly attenuated cancer malignancy both in vitro and in vivo. These findings couple hypoxia signaling to oncogenic alternative switching and highlight DCLK1-L as a promising therapeutic target for hypoxic PLOD2-rich ccRCCs.Keywords
Funding Information
- National Natural Science Foundation of China (82172913)
- 2024 Reform and Development Program of Beijing Institute of Respiratory Medicine
- Beijing Hospitals Authority Youth Programme
This publication has 77 references indexed in Scilit:
- Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar developmentGenome Research, 2011
- DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a–Dependent MechanismCancer Research, 2011
- Variants in Doublecortin- and Calmodulin Kinase Like 1, a Gene Up-Regulated by BDNF, Are Associated with Memory and General Cognitive AbilitiesPLOS ONE, 2009
- Identification of a Novel Putative Gastrointestinal Stem Cell and Adenoma Stem Cell Marker, Doublecortin and CaM Kinase-Like-1, Following Radiation Injury and in Adenomatous Polyposis Coli/Multiple Intestinal Neoplasia MiceStem Cells, 2007
- Doublecortin-like Kinase Controls Neurogenesis by Regulating Mitotic Spindles and M Phase ProgressionNeuron, 2006
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell CarcinomaMolecular and Cellular Biology, 2005
- DCAMKL1 Encodes a Protein Kinase with Homology to Doublecortin that Regulates Microtubule PolymerizationThe Journal of Neuroscience, 2000
- Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of functionOncogene, 2000
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisNature, 1999
- Expression and chromosomal localization of KIAA0369, a putative kinase structurally related to DoublecortinJournal of Human Genetics, 1998